Antithrombin binds to thrombin and makes thrombin inactivetad.
recombinant human antithrombin [HSA:462] [KO:K03911]
Prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients. It is not for treatment of thromboembolic events in hereditary antithrombin deficient patients.
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
D08858 Antithrombin alfa
Target-based classification of drugs [BR:br08310]
D08858 Antithrombin alfa (INN/USAN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine